不必要的免疫原性:从风险评估到风险管理

{"title":"不必要的免疫原性:从风险评估到风险管理","authors":"C. Scott","doi":"10.1201/B22372-28","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":142266,"journal":{"name":"Immune Aspects of Biopharmaceuticals and Nanomedicines","volume":"82 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unwanted Immunogenicity: From Risk Assessment to Risk Management\",\"authors\":\"C. Scott\",\"doi\":\"10.1201/B22372-28\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":142266,\"journal\":{\"name\":\"Immune Aspects of Biopharmaceuticals and Nanomedicines\",\"volume\":\"82 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immune Aspects of Biopharmaceuticals and Nanomedicines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/B22372-28\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immune Aspects of Biopharmaceuticals and Nanomedicines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/B22372-28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}